SCHEMBL8269151

SCHEMBL8269151

CC(=O)CCNC(=O)c1ccc(CN)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
NCOR2 Q9Y618 1/20 0.56
MCHR1 Q99705 1/20 0.55
LOXL2 Q9Y4K0 2/20 0.50
CYP1A2 P05177 1/20 0.47
TSHR P16473 1/20 0.47
NFKB1 P19838 1/20 0.47
MAOB P27338 1/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
TPSAB1 Q15661 2/20 0.46
ESRRG P62508 1/20 0.46
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA12 O43570 1/20 0.45
CA9 Q16790 1/20 0.45
ALDH1A1 P00352 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8269125 0.90 HDAC3 (0.53) HDAC3HDAC6NCOR2MCHR1LOXL2
SCHEMBL8269305 0.89 MAPK1 (0.55) HDAC3HDAC6NCOR2MCHR1ALDH1A1
SCHEMBL8269321 0.88 MAPK1 (0.58) HDAC3HDAC6NCOR2MCHR1CA2
SCHEMBL2650797 0.85 CA1 (0.62) HDAC3HDAC6NCOR2MCHR1LOXL2
SCHEMBL8269147 0.83 HDAC6 (0.59) HDAC3HDAC6NCOR2MCHR1LOXL2
SCHEMBL13113134 0.83 LMNA (0.59) HDAC3HDAC6CYP1A2TSHRNFKB1
SCHEMBL23254636 0.82 CYP1A2 (0.68) HDAC3HDAC6NCOR2MCHR1LOXL2
SCHEMBL13009911 0.82 HDAC6 (0.68) HDAC3HDAC6NCOR2MCHR1LOXL2
Hydrochloric Acid SCHEMBL6442968 0.81 KMT2A (0.59) HDAC3HDAC6NCOR2MCHR1LOXL2
SCHEMBL24386110 0.81 HDAC6 (0.58) HDAC3HDAC6NCOR2MCHR1LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040014763-A1 beta-sheet mimetics and composition and methods relating thereto MYRIAD PHARMACEUTICALS, INC. (US) 2004-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014763-A1 beta-sheet mimetics and composition and methods relating thereto TPSAB1, TPSB2, TPSD1 HDAC3 3559/4885HDAC6 2054/4885NCOR2 4819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.